MX9906989A - Metodo para el tratamiento de enfermedades prostaticas empleando analogos activos de vitamina d. - Google Patents
Metodo para el tratamiento de enfermedades prostaticas empleando analogos activos de vitamina d.Info
- Publication number
- MX9906989A MX9906989A MXPA99006989A MX9906989A MX9906989A MX 9906989 A MX9906989 A MX 9906989A MX PA99006989 A MXPA99006989 A MX PA99006989A MX 9906989 A MX9906989 A MX 9906989A MX 9906989 A MX9906989 A MX 9906989A
- Authority
- MX
- Mexico
- Prior art keywords
- active vitamin
- analogues
- treating prostatic
- prostatic diseases
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se presenta un metodo para el tratamiento de condiciones prostaticas como por ejemplo, cancer de Prostata e hiporplasia mediante la administracion de Lalia-hidroxiprevitamina D o bien vitamina D activadd o bien de una combinacion de los mismos en una forma de liberacion prolongada o bien en formulacion de liberacion retardada y prolongada. Tanto la forma de liberacion prolongada como la forma de liberacion retardada, prolongada incrementan los niveles sanguineos de vitamina D activa sin riesgo importante de hipercalcemia asociada con otras formas de administracion oral de vitamina D, para proporcionar el efecto benefico al tejido prostatico enfermo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08781910 | 1996-12-30 | ||
US08/781,910 US5763429A (en) | 1993-09-10 | 1996-12-30 | Method of treating prostatic diseases using active vitamin D analogues |
PCT/US1997/022450 WO1998029123A1 (en) | 1996-12-30 | 1997-12-10 | Method of treating prostatic diseases using active vitamin d analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9906989A true MX9906989A (es) | 2003-02-27 |
MXPA99006989A MXPA99006989A (es) | 2003-10-20 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
NZ336508A (en) | 2001-08-31 |
EP0948334A1 (en) | 1999-10-13 |
EP0948334B1 (en) | 2006-12-06 |
CN1554351A (zh) | 2004-12-15 |
PL334393A1 (en) | 2000-02-28 |
AU723835B2 (en) | 2000-09-07 |
BR9713663A (pt) | 2000-04-04 |
DE69737066T2 (de) | 2007-06-21 |
ATE347366T1 (de) | 2006-12-15 |
AU5595698A (en) | 1998-07-31 |
HUP0000558A3 (en) | 2000-12-28 |
KR20000062403A (ko) | 2000-10-25 |
WO1998029123A1 (en) | 1998-07-09 |
US6537982B1 (en) | 2003-03-25 |
US20040023934A1 (en) | 2004-02-05 |
CN1248917A (zh) | 2000-03-29 |
US5763429A (en) | 1998-06-09 |
JP2001511768A (ja) | 2001-08-14 |
CA2276606A1 (en) | 1998-07-09 |
DE69737066D1 (de) | 2007-01-18 |
HUP0000558A2 (hu) | 2000-10-28 |
CA2276606C (en) | 2008-11-25 |
CN1158081C (zh) | 2004-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL334393A1 (en) | Method of treating prostate diseases using active vitamin d analogues | |
WO2006004918A3 (en) | Method of treating prostatic diseases using a combination of vitamin d analogues and other agents | |
ATE319447T1 (de) | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen | |
IL127384A0 (en) | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity | |
NZ336511A (en) | Treating prostatic diseases using delayed and/or sustained release formulations of activated vitamin D | |
GEP20002146B (en) | Therapeutic Peptide Derivatives | |
WO1993020203A3 (en) | Stability-enhanced variants of parathyroid hormone | |
NO960445D0 (no) | Hudplaster og fremgangsmåter for å administrere testosteron | |
IL126999A0 (en) | Isobutylgaba and its derivatives for the treatment of pain | |
EP0702563A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER AND HYPERPROLIFERATIVE DISEASES | |
CA2212537A1 (en) | Therapeutic inhibitor of vascular smooth muscle cells | |
MY131805A (en) | Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis. | |
AU1195499A (en) | Thyroxine analogues having no significant hormonal activity to treat malignant tumors | |
PL323798A1 (en) | Application of derivatives of vitamin d4 in treating skin diseases | |
ATE197670T1 (de) | Parenterales busulfan zur behandlung von malignen krankheiten | |
DK1033972T3 (da) | Medikamenttilførselssystem med totrinsmålretning | |
ZA981609B (en) | Method of treating a tumor | |
UA32457C2 (uk) | Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм | |
AU9157901A (en) | Methods of treating inflammatory and immune reactions and compositions therefor | |
AU5323396A (en) | Methods of treating inflammation and compositions therefor | |
AU9369098A (en) | Therapeutic method | |
GR3037047T3 (en) | Combination therapy for advanced cancer comprising temozolomide and cisplatin | |
UA10053A (uk) | Спосіб лікування невиношування вагітності | |
MX9603833A (es) | Tratamiento mejorado del cancer con temozolomida. | |
UA43728A (uk) | Спосіб лікування раку передміхурової залози |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |